To this end we demonstrate that ME improved hepatic lipid homeostasis, attenuated obesity and improved atherogenic serum parameters in a PCSK9-dependent manner. This evidence concerns the gene PCSK9 and obesity due to melanocortin 4 receptor deficiency.